Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3964275
Reference Type
Journal Article
Title
Small bowel bacterial overgrowth and type 1 diabetes
Author(s)
Ojetti, V; Pitocco, D; Scarpellini, E; Zaccardi, F; Scaldaferri, F; Gigante, G; Gasbarrini, G; Ghirlanda, G; Gasbarrini, A
Year
2009
Is Peer Reviewed?
1
Journal
European Review for Medical and Pharmacological Sciences
ISSN:
1128-3602
Volume
13
Issue
6
Page Numbers
419-423
Web of Science Id
WOS:000272628700003
Abstract
Background: Gastrointestinal motility disorders are often present in diabetic patients (pts). Such motility dysfunctions have been attributed to autonomic neuropathy. Impaired intestinal motility is often associated with small-bowel bacterial overgrowth (SIBO) but only few studies evaluated the relationship between autonomic neuropathy and SIBO in diabetic pts.
Aim: To compare the prevalence of SIBO between type 1 diabetic (T1D) pts with and without autonomic neuropathy.
Patients and Methods: 25 pts (13 males, 12 females; mean age 44.2+/-7) affected by type 1 diabetes with normal cardiovascular autonomic test (group A) and 25 type 1 diabetic pts with abnormal cardiovascular autonomic test (group B) were submitted to hydrogen lactulose breath test.
Results: 2 out of 25 (8%) showed SIBO among group A, while 11 out of 25 (44%) showed SIBO among group B (p<0.01). Interestingly, among group B, the daily insulin requirements was significantly higher in SIBO-positive pts compared to SIBO-negative: 0.66+/-0.3 vs. 0.59+/-0.1 UI/kg (p<0.05).
Conclusions: Pts with autonomic neuropathy have a significantly higher prevalence of SIBO, that is also associated with a higher daily insulin requirements.
Keywords
Type 1 diabetes; Diabetic autonomic neuropathy; Small bowel bacterial overgrowth; Insulin requirement
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity